AI-Driven microRNA Target Discovery for CNS: Unlocking Precision Oligonucleotide Therapeutics

• Leveraging large-scale, translational multi-omics datasets to identify novel microRNA isomiRs associated with CNS disease biology and progression
• Applying AI-driven modelling to stratify patients and uncover precision oligo targets linked to distinct disease trajectories
• Enabling end-to-end translation from human data to preclinical models, supporting target validation, biomarker development, and therapeutic discovery

Speakers:

David Salzman

Founder & Chief Executive Officer

Gatehouse Bio